We wished to determine whether subtotal replacement of protein in plasma removed at plasma exchange would be adequate to prevent hypovolemia and hypoproteinemia. Seven well nourished outpatients with chronic progressive multiple sclerosis underwent 60 plasma exchanges in which two liters of plasma w
Aluminium loading during therapeutic plasma exchange
โ Scribed by Felix Monteagudo; Lucille Wood; Peter Jacobs; Peter Folb; Michael Cassidy
- Publisher
- John Wiley and Sons
- Year
- 1987
- Tongue
- English
- Weight
- 230 KB
- Volume
- 3
- Category
- Article
- ISSN
- 0733-2459
No coin nor oath required. For personal study only.
โฆ Synopsis
Graphite furnace atomic absorption spcctroscopy was used to demonstrate a fivefold increase in thc median plasma aluminium levcls of' four patients undergoing therapeutic plasmapheresis. This plasma aluminium loading resulted from contamination of albumin incorporated in the replacement fluids and took placc during its preparation. with albumin aluminium levcls of-646. 669, and 71s &liter present in thrce reprcsentative samples. Aluminium overload may result in thc development of enccphalopathy and osteomalacia in patients with rcnal impairment. indicating the need to monitor aluminium levels in the albumin-containing replacement tluids to avoid this potential hazard.
๐ SIMILAR VOLUMES
Pharmacokinetics of zidovudine (azidothymidine, AZT) were investigated after oral administration (300 mg every 8 hours) in a human immunodeficiency virus seropositive patient who was also treated with plasma exchange (60 ml/kg). Plasma AZT concentrations were measured using high performance liquid c
Plasma exchange is currently being used to treat a variety of disorders including immune complex and hematologic disorders. It has been shown that the removal of plasma removes drugs bound to plasma proteins. This case documents the removal of phenytoin during plasma exchange therapy. Total and free
## R enal indications for therapeutic plasma exchange (TPE) continue to expand and nephrologists are well trained to perform this extracorporeal blood purifi cation treatment. In this editorial, I lay out the many reasons nephrologists should consider adding TPE to their clinical practice.